Why Medifast, Inc.’s (MED) Stock Is Up 5.78%
As of Tuesday, October 27, Medifast, Inc.’s MED share price has surged by 5.78%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Jenna Brashear
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | MED | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $129.1 | $245.1 | 24% |
|
| Shares Out (Mil) | 11.1 | 20.7 | 22% |
|
| Institutional Ownership | 94.7% | 60.8% | 65% |
|
| Float (Mil) | 8.5 | 30.2 | 17% |
|
| Beta | na | 0.61 | na |
|
| Avg Daily Volume (000s) | 150 | 98 | 42% |
|
| Price Change (52-week) |
(0.4%) | 57.9% | 53% |
|
| Growth | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (16.2%) | 0.8% | 3% |
|
| Net Income (5yr) | (16.9%) | (8.6%) | 23% |
|
| EPS (5yr) | (17.0%) | (1.3%) | 16 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.1%) | (15.9%) | 51% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.010 | ($0.860) | ($0.040) | |
| Month Ago EPS | ($0.120) | ($1.150) | ($0.280) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.180) | ($1.850) | ($0.600) | |
| Year/Year Chg | (103.6%) | (49.4%) | na | |
| Financials | MED | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $317 | $571 | 36% |
|
| Net Income (TTM) (Mil) | ($26) | $1 | 22% |
|
| EPS (TTM) | ($2.321) | $0.200 | 13% |
|
| Operating Cash Flow (TTM) (Mil) | $9 | $25 | 38% |
|
| Net Cash Flow (TTM) (Mil) | ($30) | $2 | 24% |
|
| Long-Term Debt (Q1) (Mil) | $23 | $36 | 34% |
|
| Enterprise Value (Q1) (Mil) | ($17) | $339 | 1% |
|
| Valuation | MED | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.66 | 1.79 | 14% |
|
| P/E | na | 13.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | MED | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.2% | 62.9% | 80% |
|
| Net Margin | (13.6%) | 2.2% | 19% |
|
| ROA | (9.7%) | 0.9% | 26% |
|
| ROE | (12.4%) | 4.7% | 26% |
|
| Liabilities to Assets | 24.6% | 48.8% | 17% |
|
| F-Score | 3 | 5 | 18% |
|
Medifast, Inc. did not pass any screens on 10/27/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors